R&D
5 takeaways from JP Morgan 2025
I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.
Oncology
JP Morgan Week 2025 – Marianne De Backer
At JPM 2025, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO Marianne De Backer.
Digital
2025: The year ahead in pharma and life sciences
2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape relations. Regulation and deregulation may alter processes.
R&D
The future of precision psychiatry
The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and
Oncology
HPV self-collection: A step closer to eliminating cervical c...
Screening and early detection, as well as the introduction of a human papillomavirus (HPV) vaccine, have fuelled transformative strides in decreasing the burden of cervical cancer for women
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
